Navigation Links
BIT Group to Showcase Innovative Hybrid System Design at AACC
Date:7/23/2013

San Diego, CA (PRWEB) July 23, 2013

BIT Group has now concluded the full product launch of the DRG: Hybrid XL Analyzer and plans to showcase the revolutionary hybrid system design at the upcoming AACC Clinical Lab Expo in Houston, TX, USA, July 30-August 1, 2013. The analyzer, which is now in service by end users, will be part of BIT Group’s “Evolution of the Revolution” exhibit which demonstrates diagnostic system design at its best.

The DRG: Hybrid XL Analyzer‘s innovative and unique technology allows, for the first time, the simultaneous measurement of immunoassays and clinical chemistry parameters including turbidimetric tests in one work routine. BIT Group, a complete contract product development, manufacturing services and after-sales service provider to medical and industrial instrument OEM clients, partnered with DRG Diagnostics to develop the DRG:HYBRID XL Analyzer. Following the system requirements defined by DRG, BIT Group provided the hybrid technology concept and developed the core product idea and industrial design through to engineering, prototype, validation and final production.

The DRG:HYBRID XL fully-automated analyzer is ideal for small and medium-sized labs. It is also suitable for high-workload laboratories performing special routine and niche parameters automatically. The analyzer is flexible enough to measure 40 different tests from one sample or just one or two tests from 20 samples. Additionally, the unique concept of the DRG:HYBRID XL allows each user to combine individual diagnostic panels from immunoassays and clinical chemistry. Further information on the DRG:HYBRID XL Analyzer can be found on DRG’s website.

Follow BIT Group’s Hybrid videos on YouTube .

BIT Group provides contract product development, manufacturing and after-sales service for life science research, medical and IVD instrumentation. Quality standards include GMP, FDA registered, ISO13485 & 9001, QSR, Class I, II, and III. BIT global operations in USA, Germany, France, China & Japan deliver precision engineered, cost effective systems solutions. Pre-engineered BIT SMARTSOLUTIONS™ platform technologies reduce development cost and time-to-market; lean manufacturing centers and global supply chain enable competitive product cost.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10952363.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BIT Group Restructure Will Consolidate California Facilities to Form BIT USA Inc.
2. Novel study using new technologies outlines importance of California condor social groups
3. Biotech Investment Group Launches Formex, LLC
4. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
5. World Hematology & Flow Cytometry Market Reviewed in New Venture Planning Group DataPack Available at MarketPublishers.com
6. OTC Markets Group Congratulates Organovo Holdings on Move to NYSE MKT
7. KJT Group Hires Director of Health Outcomes
8. Smart Consulting Group and The Catalyst Group Form Alliance to Supply Quality Compliance Consulting Services For the Pharmaceutical Industry
9. Knowledgent Group Inc. Applies for Patent in Chemical Information Management
10. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
11. Cellular Biomedicine Group Announces Appointment of Corporate Controller
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Financial ... data, unaudited)Three Months Ended December 31,Twelve Months Ended December ... $           300$ ... Net Product Revenue 3539(10)%9498(4)%Kuvan Net ... Revenue  756025%297303(2)%Vimizim Net Product Revenue ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... 23, 2017 , ... David Nolte, PhD accepted Purdue University’s ... Purdue Research Park of West Lafayette, Indiana. , The top commercialization award ... and success with, commercializing discoveries from Purdue research. “This award is truly an ...
Breaking Biology Technology:
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... 7, 2017   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... innovative, highly flexible and award winning eClinical solution, is ... iMedNet is a proven Software-as-a-Service (SaaS) clinical research ... (EDC), but also delivers an entire suite of eClinical ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
Breaking Biology News(10 mins):